A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha(1)-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia
K. Jung et al., A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha(1)-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia, CLIN CHEM, 45(3), 1999, pp. 422-424